LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-28
DOI
10.1038/s41375-018-0182-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens
- (2017) Michael S. Khodadoust et al. NATURE
- Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
- (2016) Nakhle S. Saba et al. BLOOD
- Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
- (2016) June H. Myklebust et al. BLOOD
- Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage
- (2016) Ana C. Queirós et al. CANCER CELL
- Complementarity determining region-independent recognition of a superantigen by B-cell antigen receptors of mantle cell lymphoma
- (2016) M. Fichtner et al. HAEMATOLOGICA
- Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodies
- (2016) James Torchia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complementarity determining region-independent recognition of a superantigen by B-cell antigen receptors of mantle cell lymphoma
- (2016) M. Fichtner et al. HAEMATOLOGICA
- A phase 1 study of the PI3K inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
- (2014) B. S. Kahl et al. BLOOD
- Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor
- (2014) Klaus-Dieter Preuss et al. JOURNAL OF CLINICAL INVESTIGATION
- Towards the Generation of B-Cell Receptor Retrogenic Mice
- (2014) Jenny Freitag et al. PLoS One
- Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
- (2014) D. Chiron et al. Cancer Discovery
- Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
- (2013) Michael L. Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A
- (2011) K.-D. Preuss et al. BLOOD
- Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
- (2011) A. Hadzidimitriou et al. BLOOD
- Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert’s lymphoma nowadays?
- (2011) Sylvia Hartmann et al. HISTOPATHOLOGY
- Wegener’s granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin
- (2010) Lorenz Thurner et al. JOURNAL OF AUTOIMMUNITY
- A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS
- (2009) Klaus-Dieter Preuss et al. INTERNATIONAL JOURNAL OF CANCER
- Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma
- (2008) Ezogelin Oflazoglu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin
- (2008) Thomas Nachreiner et al. JOURNAL OF NEUROIMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started